Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) is a double-edged sword, because it decreases the risk of stroke at the cost of an increased risk of bleeding. We compared the performance of a new bleeding prediction scheme, HAS-BLED, with an older bleeding prediction scheme, HEMORR(2)HAGES, in a cohort of 'real-world' AF patients.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Thrombosis and Haemostasis |
Vol/bind | 9 |
Udgave nummer | 8 |
Sider (fra-til) | 1460-7 |
Antal sider | 8 |
ISSN | 1538-7933 |
DOI | |
Status | Udgivet - 1 aug. 2011 |
ID: 40155679